Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03565991
Title Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Pfizer

Advanced Solid Tumor


Avelumab + Talazoparib

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | BEL

Additional content available in CKB BOOST